Seeing Is Believing
Currently out of the existing stock ratings of Geoffrey Porges, 134 are a BUY (65.05%), 71 are a HOLD (34.47%), 1 are a SELL (0.49%).
Analyst Geoffrey Porges works with a stock forecast success ratio of 68.03% fulfilled within 350.46 days on average. Previously, Geoffrey Porges worked at LEERINK.
Geoffrey Porges’s has documented 419 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on RCUS, Arcus Biosciences at 04-Aug-2022.
Analyst best performing recommendations are on DOVA (DOVA PHARMACEUTICALS).
The best stock recommendation documented was for GILD (GILEAD SCIENCES) at 3/3/2020. The price target of $68 was fulfilled within 3 days with a profit of $5.02 (7.97%) receiving and performance score of 26.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
195
$27.2 (16.21%)
185
29 days ago
10/12 (83.33%)
$14.65 (8.12%)
191
Buy
189
$21.2 (12.63%)
181
2 months 19 days ago
9/11 (81.82%)
$15.71 (9.07%)
252
Buy
195
$27.2 (16.21%)
180
2 months 19 days ago
9/10 (90%)
$21.71 (12.53%)
445
Hold
165
$-2.8 (-1.67%)
157
3 months 8 days ago
11/11 (100%)
$2.96 (1.83%)
314
Buy
180
$12.2 (7.27%)
195
3 months 22 days ago
3/5 (60%)
$21.06 (13.25%)
496
What Year was the first public recommendation made by Geoffrey Porges?